Navigation Links
Neuralstem Updates ALS Stem Cell Trial Progress
Date:5/8/2012

technique in up to 18 patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

The first twelve patients were all transplanted in the lumbar (lower back) region of the spine. Of these, the initial six (Cohort A) were all non-ambulatory with permanent paralysis. The first patient was treated on January 20, 2010. Successive surgeries have followed at the rate of one every one-to-two months. The first three patients (Cohort A1) were each treated with five unilateral HSSC injections in L2-L4 lumbar segments, while the next three patients (Cohort A2) received ten bilateral injections (5 on each side) in the same region. The next six patients (Cohort B and C) were all ambulatory. Of these, the first three (Cohort B) received five unilateral injections in the L2-L4 region.  The last three patients (Cohort C) in this study group received ten bilateral injections in the same region.

The trial was then approved to progress to cervical transplantations, with two cohorts of three patients (Cohort D and Cohort E). Cohort D has received five injections in the cervical region of the spinal cord. Cohort E will receive a total of 15 injections, 5 in the cervical region and 10 in the lumbar region.

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is in an FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease, and has been awarded orphan status designation by the FDA.

In addition to ALS, the company is also targeting major central nervous system conditions with its cell therapy platform, including spinal cord injury, ischemic spastic paraplegia and chronic stroke. The company has submitt
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Neuralstem Announces Issuance of Core Technology Patent in Europe
2. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
3. Neuralstems ALS Trial on Clinical Hold
4. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
5. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
6. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
7. Neuralstem Updates ALS Clinical Trial Progress
8. Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
9. Neuralstem Updates NSI-189 Major Depression Trial
10. Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents
11. Dr. Eva Feldman, Principal Investigator, Presents Interim Data on Neuralstem ALS Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  Results of the ... Consecutive Cases Using MarginProbe for Intra-Operative Positive Margin Detection ... session at the 32 nd Annual Miami Breast ... conducted by Moshe Papa , MD, FACS, Professor ... Tel Aviv University, reports an analysis of MarginProbe,s efficiency ...
(Date:3/4/2015)... N.J. , March 4, 2015  Bayer ... Drug Administration (FDA) has accepted the company,s Biologics ... Factor VIII compound.  Bayer is seeking FDA approval ... for the treatment of hemophilia A in children ... to continually bringing new therapies to hemophilia A ...
(Date:3/4/2015)... March 4, 2015  Heska Corporation (Nasdaq: ... You to Join Its Fourth Quarter and Year End ... 2015 @ 9:00 a.m. (MST) / 11:00 a.m. (EST)Where: ... 2014 Earnings Call link on the front page of ... to the web at the address above.  Alternatively, you ...
Breaking Medicine Technology:New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 2FDA Accepts Bayer's Biologics License Application for Investigational Treatment Option in Hemophilia A 3Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2
... Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer ... the first fiscal quarter ended September 30, 2009, compared with ... of 2.2%. , The first quarter of fiscal 2010 produced ... $94,133 for the first quarter of fiscal 2009. The net ...
... 12 A new software technology is helping to ... by electronically identifying the sperm, eggs, resulting embryos and ... (IVF) treatment cycles. Using non-invasive Radio Frequency Identification (RFID), ... embryos during the course of treatment. If the wrong ...
Cached Medicine Technology:Corgenix Reports Financial Results for First Quarter of Fiscal 2010 2Corgenix Reports Financial Results for First Quarter of Fiscal 2010 3New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 2New Technology Reduces Risk of IVF Laboratory Mistakes by Electronically Identifying Sperm, Eggs and Other Materials for Each Patient 3
(Date:3/4/2015)... and Dayton, Ohio (PRWEB) March 04, 2015 ... killed in an IED explosion in Iraq, tells you ... recovering. He received some free Chiropractic care from the ... Magnetic Resonance Therapy. , This is what Harris said ... the Magnesphere, I have clarity, I feel more calm, ...
(Date:3/4/2015)... CA (PRWEB) March 04, 2015 ... have been selected by Chase Brexton Health Care, ... announced today. , Chase Brexton provides comprehensive primary ... than 30,000 patients across seven clinics in the ... adopters of electronic medical records, the organization has ...
(Date:3/4/2015)... Jose, California (PRWEB) March 04, 2015 ... CNS therapeutics market is driven by the increasing incidence ... an encouraging pipeline of late stage drugs. The unmet ... to fore the untapped potential in the market. Presently, ... effective drugs that overcome the limitations of current generation ...
(Date:3/4/2015)... 04, 2015 Follow us on ... enhancing the appearance of the skin and body, are ... of therapeutic agents to achieve the desired product properties ... society obsessed with physical beauty, youth, and achievement. Demand ... and sales of cosmetics. Growth in the market is ...
(Date:3/4/2015)... Ada Products Company, Inc ., an ... strategic partnership with the Dental Exchange in an effort ... them to engaging, inspiring ideas, products, career opportunities, and ... Dental Exchange is a first-of-its kind online resource ... other social platforms, the Dental Exchange dives much deeper ...
Breaking Medicine News(10 mins):Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 2Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 3Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Ada Products Company, Inc. Announces Strategic Partnership with the Dental Exchange 2
... University of South Florida Department of Neurosurgery and Brain ... from the National Institutes of Health to investigate the ... benefit post-stroke patients by repairing the blood-brain barrier (BBB). ... entering the brain while allowing passage of needed substances. ...
... different alcoholic beverages and drinking behaviour on the risk of ... Cohort of Swedish Men, to study the association between consumption ... pancreatitis. In total, 84,601 individuals, aged 46-84 years, were ... developed acute pancreatitis. There was a doseresponse association between ...
... (HealthDay News) -- What do a prehistoric water reptile ... than you might expect, new research indicates. A ... its embryo offers the first evidence of live birth ... have had a social structure similar to modern dolphins, ...
... Electrodiagnostic Medicine (AANEM) has awarded accreditation status to four ... Neuromuscular Center in Northeast Ohio. The EMG labs ... Ahuja Medical Center in Beachwood, Oh., UH University Suburban ... Health Center in Westlake, Oh., received accreditation. UH Case ...
... isolating cells from patients, spinal tissue within a few days ... have developed a new model of the paralyzing disease amyotrophic ... cells called astrocytes become toxic to nerve cells a ... The new model could be used to investigate many ...
... , THURSDAY, Aug. 11 (HealthDay News) -- Symptoms ... people over 80, according to a new study that ... memory loss. The study included 105 Alzheimer,s patients ... age, those 60 to 75 (young-old) and those 80 ...
Cached Medicine News:Health News:USF researchers get $2.6 million NIH grant to investigate new post-stroke therapy 2Health News:Alcohol consumption in relation to acute pancreatitis 2Health News:Prehistoric Water Reptile's Social Life Similar to Dolphins: Study 2Health News:New model of ALS is based on human cells from autopsied tissue 2Health News:New model of ALS is based on human cells from autopsied tissue 3Health News:New model of ALS is based on human cells from autopsied tissue 4Health News:Alzheimer's Harder to Detect in the Very Old 2
Inquire...
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Silicone Compression Mat, Bulk...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Medicine Products: